| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-06 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-06 |